Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On
The foregoing description of the Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to the complete text of the Certificate of Amendment, a copy of which is filed with this report as Exhibit 3.1 and is incorporated into this report by reference.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On
Proposal 1. Election of directors.
The Company's stockholders elected each of the following individuals to serve as class II directors for a three-year term ending at the Company's 2025 annual meeting of stockholders and until his or her respective successor is duly elected and qualified, or until his or her earlier death, resignation or removal, with the votes cast as follows:
Name Votes For Votes Withheld Broker Non-Votes Alexis Borisy 56,616,663.04 35,194,356.10 6,592,067.00 Mark Murcko, Ph.D. 78,595,708.04 13,215,311.10 6,592,067.00 Laura Shawver, Ph.D. 60,543,706.04 31,267,313.10 6,592,067.00
Proposal 2. Non-binding advisory vote on executive compensation.
The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers, with the votes cast as follows:
Votes For Votes Against Abstain Broker Non-Votes 83,645,401.04 3,551,366.10 4,614,252.00 6,592,067.00
Proposal 3. Non-binding advisory vote on the frequency of future non-binding advisory votes on executive compensation.
The Company's stockholders approved, on a non-binding, advisory basis, to set the frequency of future non-binding advisory votes on the compensation of the Company's named executive officers, to every one year, with the votes cast as follows:
One Year Two Years Three Years Abstain Broker Non-Votes 86,491,256.04 9,024.00 77,927.10 5,232,812.00 6,592,067.00
Proposal 4. Approval of amendment to the Company's Fourth Amended and Restated Certificate of Incorporation.
The Company's stockholders approved an amendment to the Company's Fourth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 shares to 300,000,000 shares, with the votes cast as follows:
Votes For Votes Against Abstain Broker Non-Votes 93,032,987.04 758,293.10 4,611,806.00 0.00
Proposal 5. Ratification of appointment of independent registered public accounting firm.
The Company's stockholders ratified the appointment of
Votes For Votes Against Abstain Broker Non-Votes
93,772,475.04 15,739.10 4,614,872.00 0.00
No other matters were submitted to or voted on by the Company's stockholders at the Annual Meeting. --------------------------------------------------------------------------------
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits 3.1 Certificate of Amendment of Fourth Amended and Restated Certificate of Incorporation ofRelay Therapeutics, Inc. , filed with the Secretary of State of theState of Delaware onMay 27, 2022 . 104 Cover Page Interactive Data File (embedded within Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source